408 related articles for article (PubMed ID: 28826610)
1. Calling Chromosome Alterations, DNA Methylation Statuses, and Mutations in Tumors by Simple Targeted Next-Generation Sequencing: A Solution for Transferring Integrated Pangenomic Studies into Routine Practice?
Garinet S; Néou M; de La Villéon B; Faillot S; Sakat J; Da Fonseca JP; Jouinot A; Le Tourneau C; Kamal M; Luscap-Rondof W; Boeva V; Gaujoux S; Vidaud M; Pasmant E; Letourneur F; Bertherat J; Assié G
J Mol Diagn; 2017 Sep; 19(5):776-787. PubMed ID: 28826610
[TBL] [Abstract][Full Text] [Related]
2. Analyzing the cancer methylome through targeted bisulfite sequencing.
Lee EJ; Luo J; Wilson JM; Shi H
Cancer Lett; 2013 Nov; 340(2):171-8. PubMed ID: 23200671
[TBL] [Abstract][Full Text] [Related]
3. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
[TBL] [Abstract][Full Text] [Related]
4. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
[TBL] [Abstract][Full Text] [Related]
5. Ioncopy: an R Shiny app to call copy number alterations in targeted NGS data.
Budczies J; Pfarr N; Romanovsky E; Endris V; Stenzinger A; Denkert C
BMC Bioinformatics; 2018 Apr; 19(1):157. PubMed ID: 29699497
[TBL] [Abstract][Full Text] [Related]
6. High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods.
Su D; Zhang D; Chen K; Lu J; Wu J; Cao X; Ying L; Jin Q; Ye Y; Xie Z; Xiong L; Mao W; Li F
J Exp Clin Cancer Res; 2017 Sep; 36(1):121. PubMed ID: 28882180
[TBL] [Abstract][Full Text] [Related]
7. Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene Testing.
Hiemenz MC; Kadauke S; Lieberman DB; Roth DB; Zhao J; Watt CD; Daber RD; Morrissette JJ
PLoS One; 2016; 11(4):e0152851. PubMed ID: 27043212
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
Yao R; Yu T; Qing Y; Wang J; Shen Y
Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical setting.
Hinchcliffe M; Le H; Fimmel A; Molloy L; Freeman L; Sullivan D; Trent RJ
Pathology; 2014 Jan; 46(1):60-8. PubMed ID: 24300713
[TBL] [Abstract][Full Text] [Related]
10. Genome-Wide Copy Number Variation Detection Using NGS: Data Analysis and Interpretation.
Shen W; Szankasi P; Durtschi J; Kelley TW; Xu X
Methods Mol Biol; 2019; 1908():113-124. PubMed ID: 30649724
[TBL] [Abstract][Full Text] [Related]
11. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
12. Targeted DNA methylation analysis by next-generation sequencing.
Masser DR; Stanford DR; Freeman WM
J Vis Exp; 2015 Feb; (96):. PubMed ID: 25741966
[TBL] [Abstract][Full Text] [Related]
13. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data.
Favero F; Joshi T; Marquard AM; Birkbak NJ; Krzystanek M; Li Q; Szallasi Z; Eklund AC
Ann Oncol; 2015 Jan; 26(1):64-70. PubMed ID: 25319062
[TBL] [Abstract][Full Text] [Related]
14. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.
Luthra R; Patel KP; Routbort MJ; Broaddus RR; Yau J; Simien C; Chen W; Hatfield DZ; Medeiros LJ; Singh RR
J Mol Diagn; 2017 Mar; 19(2):255-264. PubMed ID: 28017569
[TBL] [Abstract][Full Text] [Related]
15. DNA Methylation Analysis by Bisulfite Conversion Coupled to Double Multiplexed Amplicon-Based Next-Generation Sequencing (NGS).
Bashtrykov P; Jeltsch A
Methods Mol Biol; 2018; 1767():367-382. PubMed ID: 29524146
[TBL] [Abstract][Full Text] [Related]
16. Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors.
Paasinen-Sohns A; Koelzer VH; Frank A; Schafroth J; Gisler A; Sachs M; Graber A; Rothschild SI; Wicki A; Cathomas G; Mertz KD
Neoplasia; 2017 Mar; 19(3):196-206. PubMed ID: 28161563
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Screening of Gene Copy Number Aberrations in Formalin-Fixed, Paraffin-Embedded Solid Tumors Using Molecular Inversion Probe-Based Single-Nucleotide Polymorphism Array.
Singh RR; Mehrotra M; Chen H; Almohammedsalim AA; Sahin A; Bosamra A; Patel KP; Routbort MJ; Lu X; Ronald A; Mishra BM; Virani S; Medeiros LJ; Luthra R
J Mol Diagn; 2016 Sep; 18(5):676-687. PubMed ID: 27392636
[TBL] [Abstract][Full Text] [Related]
18. SILO: A Computational Method for Detecting Copy Number Gain in Clinical Specimens Analyzed on a Next-Generation Sequencing Platform.
Miller N; Bouma M; Sabatini L; Gulukota K
J Mol Diagn; 2021 Oct; 23(10):1241-1248. PubMed ID: 34365010
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation detection at single base resolution using targeted next generation bisulfite sequencing and cross validation using capillary sequencing.
Bhat S; Mallya S; Varghese VK; Jayaram P; Chakrabarty S; Joshi KS; Nesari TM; Satyamoorthy K
Gene; 2016 Dec; 594(2):259-267. PubMed ID: 27637516
[TBL] [Abstract][Full Text] [Related]
20. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies.
Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P
Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
